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Abstract
Background: Inpatient utilization associated with incidence of geriatric new-onset epilepsy has not been
characterized in any large study, despite recognized high levels of risk factors (comorbidity).
Methods: Retrospective study using administrative data (Oct ‘01-Sep ‘05) from the Veterans Health Administration
from a nationwide sample of 824,483 patients over age 66 in the retrospective observational Treatment In Geriatric
Epilepsy Research (TIGER) study. Psychiatric and medical hospital admissions were analyzed as a function of patient
demographics, comorbid psychiatric, neurological, and other medical conditions, and new-onset epilepsy.
Results: Elderly patients experienced a 15% hospitalization rate in FY00 overall, but the subset of new-onset
epilepsy patients (n = 1,610) had a 52% hospitalization rate. New-onset epilepsy was associated with three-fold
increased relative odds of psychiatric admission and nearly five-fold increased relative odds of medical admission.
Among new-onset epilepsy patients, alcohol dependence was most strongly associated with psychiatric admission
during the first year after epilepsy onset (odds ratio = 5.2; 95% confidence interval 2.6-10.0), while for medical
admissions the strongest factor was myocardial infarction (odds ratio = 4.7; 95% confidence interval 2.7-8.3).
Conclusion: From the patient point of view, new-onset epilepsy was associated with an increased risk of medical
admission as well as of psychiatric admission. From an analytic perspective, omitting epilepsy and other
neurological conditions may lead to overestimation of the risk of admission attributable solely to psychiatric
conditions. Finally, from a health systems perspective, the emerging picture of the epilepsy patient with
considerable comorbidity and demand for healthcare resources may merit development of practice guidelines to
improve coordinated delivery of care.
Background
Epilepsy is a common neurologic disorder among per-
sons over age 65, with a prevalence estimated at 5.7
cases per 1,000 older adults [1,2]. Incidence may range
from 16 to 51 cases per 100,000 in population-based
studies [3]. While the diagnosis and treatment of sei-
z u r e si nt h i sp o p u l a t i o ni sac h a l l e n g ei ni t so w nr i g h t ,
comorbid conditions may lead to hospital admissions
for reasons that go beyond epilepsy. Comorbidities with
elevated occurrence among epilepsy patients include
digestive system disorders, stroke, respiratory disorders,
dementia, migraine and other pain conditions as well as
psychiatric disorders [3-5]. If the risk and nature of
non-epilepsy hospitalizations are substantial, this means
that elderly new-onset epilepsy patients are a special
population in whom clinicians should pay careful atten-
tion to identifying and addressing comorbidity [6]. In
this context, epilepsy becomes a marker for a constella-
tion of serious conditions that go substantially beyond
the epilepsy itself. Yet little is known about the rate and
nature of hospitalizations among elderly patients with
new-onset epilepsy.
Previous research on older epilepsy patients treated in
the VA noted a large burden of psychiatric disorders,
[7] which may contribute directly to inpatient stays. Sei-
zure disorders, other medical conditions including cere-
brovascular disorders, [5] or psychiatric conditions may
necessitate inpatient admission among elderly patients
with epilepsy [8]. These inpatient experiences have
rarely been described outside economic analyses and
studies of emergency department use [9-11].
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Research (TIGER) study of new-onset late-life epilepsy,
we examined risk factors for psychiatric and medical
admissions among geriatric patients, comparing those
with new-onset epilepsy to those without epilepsy,
expecting that TIGER patients would have higher rela-
tive odds of admission. Next we analyzed admissions of
new-onset epilepsy patients only, to better understand
risk factors for medical and psychiatric hospitalization in
that clinically unique subset of patients.
Methods
Study design
The TIGER study is a national retrospective, observa-
tional study of new-onset epilepsy in geriatric patients
receiving care in the Veterans Health Administration
(VA).
Sample
The sample consisted of VA patients aged 66 or older in
fiscal year 2000 (FY2000; Oct 1999-Sep 2000). The prior
two years were used to establish epilepsy status as no
epilepsy, ongoing epilepsy, or new-onset epilepsy. Based
on a validated algorithm comparing chart review data to
administrative and Medicare ICD-9 codes and electronic
medication records, both diagnosis of a seizure disorder
(ICD-9 code 780.3 or 345) and a current anti-epileptic
drug (AED’s) prescription were required to establish epi-
lepsy status. The algorithm has a positive predictive
v a l u eo f0 . 9 8[ 1 2 ] .N e w - o n s e t epilepsy was defined by
use of the VA without diagnosis of a seizure disorder in
FY1998-FY1999, and diagnosis of seizure disorder plus
receipt of AED’s in FY2000 but not in FY1998-FY1999.
Patients with previous diagnosis of epilepsy (prevalent
cases) were excluded (n = 41,867). This study was
approved by the Institutional Review Boards at the Uni-
versity of Texas Health Science Center at San Antonio
and at the Bedford and Hines VA Medical Centers prior
to initiation.
Data sources
Administrative data extracts of the VA’s all-electronic
medical record provided measures of diagnoses, inpati-
ent and outpatient utilization, and demographics.
Measures
The years FY1998-FY1999 were also used to establish
neurological conditions associated with seizure disorders
present prior to determining epilepsy onset. These
“prior” conditions included diagnosis of senile dementia
per Krishnan, [13] cerebrovascular disorders (ICD-9
codes 430-438), brain tumor (ICD-9 191), head injury
(ICD-9 851-854), and other neurological conditions
such as multiple sclerosis and Parkinsons [14].
Then administrative data extracts determined hospita-
lizations during the first year (FY2000) and comorbid
conditions, while the second year (FY2001) established
ongoing use of the VA healthcare system (yes or no).
Sociodemographic measures included age group (young-
old 65-74 years of age, older 75-84, oldest 85+), ethni-
city/race (African-American or Hispanic versus white),
and gender. Patients missing data on race were identi-
fied and excluded (20% of sample).
The predictors of interest were demographic mea-
sures, prior neurological conditions, other comorbid
medical conditions, psychiatric conditions, and new-
onset epilepsy. Selim comorbidity indicators, developed
on VA patient survey data and subsequently adapted to
administrative data [15,16] were employed to identify
the comorbid medical and psychiatric conditions. The
Selim indicators assess diagnoses for diabetes, hyperten-
sion, myocardial infarct, angina, arrhythmia, congestive
heart failure, and transient ischemic attacks, among
other conditions. The Selim indicator of seizures was
not included in analytic models as these diagnosis codes
were incorporated into the new-onset epilepsy indicator,
leaving 29 Selim physical comorbidity indicators in the
model. Psychiatric indicators assessed diagnosis with
schizophrenia (ICD-9 295), bipolar disorder (ICD-9
296.0-296.1, 296.4-296.8), depressive disorder (ICD-9
296.2-296.3, 300.4, 311), post-traumatic stress disorder
(ICD-9 309.81), alcohol dependence (ICD-9 303, 305.0),
and anxiety disorders (ICD-9 300.00, 300.02, 300.09),
[15] to which was added an indicator of substance use
disorder (ICD-9 291, 292, 303-305).
Outcomes were hospital admission events (any versus
none). Psychiatric admissions were identified by a hospi-
talization with a primary diagnosis of a psychiatric disor-
der in the range reviewed above including those not
specified (ICD-9 codes 290-311). Psychiatric diagnoses
in the range ICD-9 312-319 are related to childhood/
mental retardation and are extremely rare in the post-
military population that uses the VA. There were 25
persons with admissions attributed to this range of diag-
nosis codes; these individuals were excluded from the
study, leaving a sample size of 824,483 persons. Medical
admissions were all those with a primary diagnosis out-
side the range 290-319. Epilepsy-specific admissions, a
subset of medical admissions, were admissions with a
primary diagnosis of a seizure disorder (ICD-9 345,
780.39). We report these separately to establish that
medical admissions of the new-onset epilepsy patients
were not solely related to their epilepsy.
Analysis
After characterizing the sample with descriptive statis-
tics, adjusted logistic regression models assessed factors
in admission (yes/no) in FY2000, including demographic
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tions, clinical covariates (medical and psychiatric comor-
bidities) to adjust for between-group differences, and
new-onset epilepsy. Separate models assessed each out-
come: psychiatric admission and medical admission. A
second set of models restricted to the subset of patients
with new-onset epilepsy determined factors in hospitali-
zation specific to TIGER patients. All models included
an indicator of loss to follow-up, which identified
patients for whom no data was found in FY2001. This
included patients who died in FY2001, left the VA sys-
tem, or remained hospitalized past the end of the obser-
vation period at the end of FY2001. In analysis, many
modest effects achieve statistical significance when the
sample is very large as in this study, therefore we
focused on odds ratios indicating medium (≥1.5 for
positive associations and ≤0.67 for inverse associations)
or large (≥2o ro f≤.5) effect sizes [17]. Model fit was
reported by the c-statistic, a measure which ranges from
0.5 for model fit no better than by chance to 1.0 for per-
fect fit.
Results
Sample
The TIGER study of 824,483 patients aged 66 or older
in FY2000 included 16,814 women (2%). Consistent with
U. S. military recruitment trends, most patients were
Anglo males with 12% African-American and 5% Hispa-
n i cp a t i e n t s( T a b l e1 ) .T h e r ew e r e1 , 6 1 0p a t i e n t sw i t h
new-onset epilepsy (TIGER patients) in the sample
(0.2%). TIGER patients resembled non-epilepsy patients
on most demographic measures (age, gender) but dif-
fered in that they were more likely to be African-Ameri-
can (20% of TIGER patients versus 12% of non-TIGER
patients, chi-square = 115.6, df = 2, p < .0001). Sum-
ming the included and excluded patients for the
denominator and adjusting for the deleted cases missing
data on race, the incidence of epilepsy in late-life VA
patients was 156 cases per 100,000 patients while preva-
lence was 42 per 1,000.
Comorbidity
New-onset epilepsy patients had high rates of the prior
neurological conditions studied: cerebrovascular dis-
ease (40% TIGER versus 17% other VA patients over
age 66), dementia (18% versus 7%), brain tumor (2%
versus 1%) and head injury (2% versus <1%). Psychia-
tric comorbid conditions were also common, especially
depressive disorders which were diagnosed in 17% of
new-onset epilepsy patients compared to 9% of non-
epilepsy patients. Overall, these older patients averaged
3.0 (± 2.0) Selim physical comorbid conditions of 29
assessed conditions and 0.22 (± 0.56) Selim mental ill-
nesses of six assessed.
Outcomes
The proportion of geriatric patients with a hospital
admission varied by new-onset epilepsy status. Overall,
the proportion hospitalized was 15% (121,118) in FY00
but it was 52% (844) for the subset of new-onset epi-
lepsy patients. Most patients had medical admissions
(14%; n = 116,357) while 1% (7,830) experienced psy-
chiatric admissions; for TIGER patients these propor-
tions were 50% (809) and 6% (91). Some patients had
both types of admissions: 0.4% (3,069) of the large sam-
ple and 3.5% (56) of the new-onset epilepsy patients.
Among TIGER patients, roughly one-third with medical
admissions were admitted specifically for epilepsy as the
primary diagnosis for the hospitalization (ICD9 codes
345.xx or 780.39). Only 19 TIGER patients had both
psychiatric and epilepsy-specific admissions. The next
year in FY01, 14% of all patients (106,483) were
admitted as were 29% of new-onset epilepsy patients
(387). TIGER patients were more likely to be lost from
the study (chi-square 59.4, d.f. = 2, p < .0001), primarily
through death.
Days of hospitalization for medical admissions aver-
aged 19.5 days (± 29.8; median 9 days) for the entire
sample, and were markedly higher for TIGER patients
(median 14.0 vs 9.0 days; Wilcoxon 2-sample z-statistic
= 10.4; two-sided p < .0001). Individuals with new-onset
epilepsy had somewhat more inpatient days for psychia-
tric reasons compared to other patients: mean 52.7 (±
58.7) versus 40.8 (± 47.3), and median 32 vs 24 days
(Wilcoxon 2-sample z-statistic = 2.03; two-sided p =
.04).
In the covariate-adjusted model, psychiatric hospital
admission was primarily associated with psychiatric dis-
orders for these geriatric patients but also showed
strong associations with prior neurological conditions:
cerebrovascular disease (OR = 1.5, 95% CI 1.4-1.6),
dementia (OR = 9.5, 95% CI 9.0-10.0), alcohol depen-
dence (OR = 11.7; 95% CI 10.9-12.5), schizophrenia (OR
= 6.3; 95% CI 5.9-6.7), bipolar disorder (OR = 4.6; 95%
CI 4.2-5.0), depression (OR = 2.8; 95% CI 2.7-3.0). New-
onset epilepsy was also associated with increased risk of
psychiatric admission (OR = 2.9, 95% CI 2.2-3.7). An
inverse relationship with psychiatric admission was
noted for Hispanic ethnicity (OR = 0.58, 95% CI 0.51-
0.65). Some physical conditions had modest associations,
with hepatitis strongest among these (OR = 1.5; 95% CI
1.3-1.7). Complete multivariable results are reported in
Table 2.
In the model of medical admissions among 824,483
geriatric patients, significant factors were noted in each
domain. The demographic factor of African American
race was associated with greater risk of medical admis-
sion (OR = 1.5; 95% CI 1.4-1.5). Among prior neurolo-
gical conditions, new-onset epilepsy imparted 5-fold
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Other neurologic risk factors roughly doubled relative
odds of medical admission: dementia (OR = 2.2; 95%
CI 2.1-2.3), head injury (OR = 2.2; 95% CI 2.0-2.4),
brain tumor (OR = 1.9; 95% CI 1.8-2.1), cerebrovascu-
lar disease (OR = 1.8; 95% CI 1.7-1.8), and other neu-
rological disorders such as multiple sclerosis and
Parkinsons (OR = 1.8; 95% CI 1.8-1.9). Many other
physical ills were associated with medical admission,
notably comorbid gall bladder disorders (OR = 7.4;
95% CI 6.9-7.8), myocardial infarct (OR = 4.7; 95% CI
4.5-4.8), angina (OR = 3.5; 95% CI 3.4-3.6), and anemia
(OR = 3.2; 95% CI 3.1-3.3). Among mental disorders,
significant associations with medical admission were
found for alcohol dependence (OR = 2.3; 95% CI 2.2-
2.4) and schizophrenia (OR = 1.5; 95% CI 1.4-1.6;
Table 3).
For the subset of 1,610 new-onset epilepsy patients,
the model of psychiatric admissions found an effect of
prior dementia (OR = 2.3; 95% CI 1.4-4.0), and hyper-
tension was a risk factor for psychiatric admission (OR
= 2.2; 95% CI 1.2-4.1) while peripheral vascular disease
Table 1 Description of Elderly Patients in the Veterans Health Administration in FY2000
Characteristic TIGER Cohort with New-Onset Epilepsy Non-Epilepsy Patients Total Sample
Number of patients 1,610 822,873 824,483
N (%) or Mean (SD) N (%) or Mean (SD) N (%) or Mean (SD)
Age
65-74 Years 850 (53%) 448,274 (54%) 449,124 (54%)
75-84 Years 706 (44%) 345,985 (42%) 346,691(42%)
85 or older 54 (3%) 28,614 (3%) 28,668 (3%)
Ethnicity/Race
Hispanic 83 (5%) 44,612 (5%) 44,695 (5%)
African-American 323 (20%) 94,669 (12%) 94,992 (12%)
Anglo 1,204 (75%) 683,592 (83%) 684,796 (83%)
Gender
Women 24 (1.5%) 16,790 (2%) 16,814 (2%)
Men 1,586 (98.5%) 806,083 (98%) 807,669 (98%)
Neurological conditions, other 150 (9%) 32,114 (4%) 32,264 (4%)
Cerebrovascular disease 639 (40%) 136,306 (17%) 136,945 (17%)
Dementia 284 (18%) 60,588 (7%) 60,872 (7%)
Brain tumor 27 (2%) 5,306 (1%) 5,333 (1%)
Head injury 25 (2%) 3,565 (<1%) 3,590 (<1%)
Any psychiatric condition 801 (50%) 199,480 (24%) 200,281 (24%)
Anxiety 152 (9%) 43,292 (5%) 43,444 (5%)
Depression 280 (17%) 71,623 (9%) 71,903 (9%)
Post-traumatic stress disorder 77 (5%) 22,382 (3%) 22,459 (3%)
Bipolar disorder 47 (3%) 9,729 (1%) 9,776 (1%)
Schizophrenia 80 (5%) 15,954 (2%) 16,034 (2%)
Alcohol dependence 104 (6%) 16,922 (2%) 17,026 (2%)
Substance abuse 211 (13%) 55,554 (7%) 55,765 (7%)
Hypertension 1,147 (71%) 510,382 (62%) 511,529 (62%)
Dyslipidemia 449 (28%) 265,785 (32%) 266,234 (32%)
Diabetes 497 (31%) 221,810 (27%) 222,307 (27%)
FY00 psychiatric admission 91 (6%) 7,739 (1%) 7,830 (1%)
FY00 medical admission 809 (50%) 115,548 (14%) 116,357 (14%)
FY00 epilepsy-related admission
(a subset of medical admissions)
263 (16%) 4 (<1%) 267 (<1%)
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Age and race/ethnicity were not significantly related.
Psychiatric diagnoses were related as expected, especially
alcohol dependence (OR = 5.2, 95% CI 2.6-10.0) and
schizophrenia (OR = 3.5; 95% CI 1.7-7.3). Details are
reported in Table 4.
The model of medical admissions among new-onset
epilepsy patients found that both African American race
(OR = 2.3; 95% CI 1.7-3.1) and Hispanic ethnicity (OR
= 2.4; 95% CI 1.4.4.2) were associated with greater rela-
tive odds of admission. The prior neurological factors of
cerebrovascular disease (OR = 1.7; 95% CI 1.3-2.2) and
dementia (OR = 1.5; 95% CI 1.1-2.1) were significant.
Among physical disorders, most strongly related were
Table 2 Factors Associated with Psychiatric Admissions
among Geriatric Patients (N = 824,483; c-statistic = 0.95)
Effect Odds
Ratio
95% CI Significant
(CI excludes 1.0)
Alcohol dependence 11.70 10.9-12.5 *
Dementia 9.50 9.00-10.0 *
Schizophrenia 6.29 5.87-6.73 *
Bipolar disorder 4.59 4.23-4.97 *
New-onset epilepsy 2.87 2.24-3.67 *
Depression 2.83 2.68-2.99 *
Lost to follow-up 2.01 1.89-2.14 *
PTSD 1.67 1.52-1.82 *
Cerebrovascular disease 1.50 1.42-1.59 *
Hepatitis 1.46 1.27-1.68 *
Neurological conditions,
other
1.42 1.32-1.53 *
Anemia 1.40 1.32-1.50 *
Anxiety 1.40 1.30-1.50 *
COPD 1.38 1.30-1.45 *
Peptic ulcer 1.38 1.24-1.53 *
Age 85 or older 1.37 1.23-1.52 *
Brain tumor 1.30 1.03-1.65 *
Irregular heartbeat 1.24 1.17-1.33 *
Heart attack 1.23 1.12-1.36 *
Female 1.22 1.05-1.43 *
Head injury 1.22 1.00-1.49 *
African American 1.21 1.13-1.30 *
Hypertension 1.21 1.15-1.28 *
Low-back pain 1.18 1.10-1.27 *
Other arthritic disease 1.17 1.05-1.29 *
Enlarged prostate 1.16 1.10-1.23 *
Hip problems 1.11 0.96-1.27 n.s.
Prostatitis 1.10 0.90-1.35 n.s.
Osteoarthritis 1.07 1.00-1.13 *
Gallbladder disease 0.98 0.79-1.21 n.s.
Gout 0.98 0.87-1.11 n.s.
Peripheral vascular disease 0.97 0.89-1.05 n.s.
Angina 0.95 0.86-1.05 n.s.
Diverticulitis 0.95 0.84-1.08 n.s.
Congestive Heart Failure 0.94 0.87-1.01 n.s.
Age 75-84 years 0.92 0.87-0.97 *
Cancer 0.84 0.79-0.90 *
Rheumatoid arthritis 0.84 0.68-1.03
Cataracts 0.80 0.75-0.86 *
Inflammatory bowel disease 0.64 0.43-0.96 *
Hispanic 0.58 0.51-0.65 *
Table 3 Factors Associated with Medical Admissions
among Geriatric Patients (N = 824,483; c-statistic = 0.86)
Effect Odds Ratio 95% CI
Gallbladder disease 7.37 6.94-7.82 *
New-onset epilepsy 4.84 4.29-5.46 *
Heart attack 4.68 4.55-4.81 *
Lost to follow-up 3.74 3.67-3.82 *
Angina 3.51 3.42-3.60 *
Anemia 3.20 3.14-3.26 *
Hip problems 2.75 2.63-2.88 *
Irregular heartbeat 2.59 2.54-2.64 *
Cancer 2.45 2.41-2.49 *
COPD 2.41 2.37-2.45 *
Hepatitis 2.38 2.25-2.51 *
Alcohol dependence 2.30 2.21-2.40 *
Congestive Heart Failure 2.21 2.17-2.25 *
Dementia 2.20 2.15-2.25 *
Head injury 2.19 2.01-2.38 *
Peptic ulcer 1.97 1.91-2.04 *
Brain tumor 1.93 1.80-2.07 *
Inflammatory bowel disease 1.92 1.76-2.10 *
Peripheral vascular disease 1.83 1.79-1.87 *
Neurological conditions, other 1.81 1.75-1.87 *
Cerebrovascular disease 1.75 1.72-1.78 *
Diverticulitis 1.73 1.68-1.79 *
Prostatitis 1.55 1.46-1.64 *
Hypertension 1.48 1.45-1.50 *
Schizophrenia 1.48 1.41-1.55 *
Rheumatoid arthritis 1.47 1.40-1.54 *
African American 1.45 1.42-1.48 *
Enlarged prostate 1.40 1.37-1.42 *
Female 1.39 1.32-1.47 *
Gout 1.33 1.29-1.38 *
Other arthritic disease 1.30 1.26-1.34 *
Low-back pain 1.26 1.23-1.28 *
Depression 1.24 1.21-1.27 *
Hispanic 1.20 1.16-1.24 *
Osteoarthritis 1.14 1.12-1.16 *
Anxiety 1.12 1.09-1.16 *
Age 85 or older 1.11 1.07-1.16 *
Cataracts 1.10 1.08-1.12 *
Bipolar disorder 1.07 1.01-1.14 *
Age 75-84 years 0.90 0.89-0.92 *
PTSD 0.82 0.79-0.86 *
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arrhythmias (OR = 2.3; 95% CI 1.7-3.1). Finally, the
mental disorder alcohol dependence was again corre-
lated with medical admission (OR = 2.5; 95% CI 1.5-4.1;
Table 5).
Discussion
To our knowledge, this is the first paper to examine the
high rates of hospital admissions among elderly new-
onset epilepsy patients (52%), relative to elderly patients
without epilepsy (15%). Results suggest that the
Table 4 Factors Associated with Psychiatric Admissions
among Geriatric Patients with New-Onset Epilepsy
(N = 1,610; c-statistic = 0.83).
Effect Odds
Ratio
95% CI Significant
(CI excludes 1.0)
Alcohol dependence 5.17 2.66-10.1 *
Schizophrenia 3.38 1.63-7.01 *
Bipolar disorder 2.79 1.12-6.96 *
Dementia 2.24 1.32-3.81 *
Hypertension 2.14 1.16-4.05 *
Depression 2.14 1.27-3.62 *
PTSD 2.10 0.94-4.68 n.s.
Hepatitis 2.03 0.58-7.02 n.s.
Anxiety 1.81 0.96-3.41 n.s.
Other arthritic disease 1.75 0.80-3.83 n.s.
Gout 1.60 0.58-4.41 n.s.
COPD 1.50 0.91-2.49 n.s.
Angina 1.46 0.69-3.08 n.s.
Ulcer peptic 1.44 0.59-3.55 n.s.
Low-back pain 1.43 0.79-2.60 n.s.
Irregular heartbeat 1.39 0.79-2.49 n.s.
Cerebrovascular
disease
1.37 0.83-2.26 n.s.
Anemia 1.33 0.76-2.32 n.s.
Diverticulitis 1.32 0.49-3.61 n.s.
Age 75-84 years 1.27 0.77-2.09 n.s.
Neurological
conditions, other
1.27 0.63-2.59 n.s.
Hip problems 1.27 0.42-3.79 n.s.
Rheumatoid arthritis 1.27 0.25-6.38 n.s.
Heart attack 1.26 0.61-2.87 n.s.
Lost to follow-up 1.24 0.65-2.37 n.s.
African American 1.22 0.67-2.20 n.s.
Enlarged prostate 1.18 0.70-2.01 n.s.
Cataracts 0.99 0.54-1.79 n.s.
CHF 0.99 0.53-1.86 n.s.
Hispanic 0.98 0.34-2.79 n.s.
Thyroid 0.81 0.34-1.93 n.s.
Gallbladder disease 0.80 0.14-4.55 n.s.
Osteoarthritis 0.77 0.42-1.39 n.s.
Diabetes 0.76 0.44-1.29 n.s.
Cancer 0.64 0.34-1.19 n.s.
Prostatitis 0.60 0.05-7.16 n.s.
Age 85 or older 0.53 0.07-4.19 n.s.
Brain tumor 0.43 0.05-4.09 n.s.
Head injury 0.35 0.04-2.89 n.s.
Peripheral vascular
disease
0.34 0.14-0.84 *
Table 5 Factors Associated with Medical Admissions
among Geriatric Patients with New-Onset Epilepsy
(N = 1,610; c-statistics = 0.80).
Effect Odds
Ratio
95% CI Significant
(CI excludes 1.0)
Heart attack 4.74 2.72-8.28 *
Gallbladder disease 3.90 1.21-12.58 *
Anemia 2.93 2.09-4.10 *
Angina 2.57 1.57-4.22 *
Alcohol dependence 2.46 1.49-4.08 *
Head injury 2.44 0.88-6.81 n.s.
Hispanic 2.35 1.35-4.09 *
Brain tumor 2.30 0.74-7.14 n.s.
Irregular heartbeat 2.26 1.66-3.08 *
African American 2.25 1.67-3.05 *
Lost to follow-up 2.12 1.53-2.94 *
Cancer 2.08 1.56-2.78 *
Hip problems 2.05 0.98-4.27 n.s.
Thyroid 1.87 1.15-3.03 *
Ulcer peptic 1.73 0.94-3.16 n.s.
Cerebrovascular
disease
1.72 1.34-2.19 *
COPD 1.66 1.27-2.18 *
Schizophrenia 1.65 0.93-2.90 n.s.
Peripheral vascular
disease
1.61 1.11-2.34 *
Dementia 1.54 1.12-2.12 *
Enlarged prostate 1.53 1.16-2.02 *
Hypertension 1.51 1.15-1.98 *
Diabetes 1.46 1.13-1.89 *
Rheumatoid arthritis 1.46 0.59-3.64 n.s.
CHF 1.44 1.02-2.05 *
Neurological
conditions, other
1.39 0.92-2.10 n.s.
Anxiety 1.29 0.84-1.98 n.s.
Prostatitis 1.27 0.41-3.93 n.s.
Other arthritic disease 1.22 0.75-1.99 n.s.
Osteoarthritis 1.16 0.86-1.56 n.s.
Gout 1.11 0.59-2.07 n.s.
Bipolar disorder 1.11 0.55-2.25 n.s.
Cataracts 1.09 0.81-1.47 n.s.
PTSD 1.07 0.60-1.91 n.s.
Depression 1.00 0.72-1.39 n.s.
Hepatitis 0.98 0.37-2.62 n.s.
Age 85 or older 0.90 0.46-1.78 n.s.
Low-back pain 0.89 0.63-1.25 n.s.
Diverticulitis 0.84 0.46-1.53 n.s.
Age 75-84 years 0.81 0.64-1.04 n.s.
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not only for recurrent seizures but also for hospitaliza-
tion for a diversity of medical and psychiatric condi-
tions. In this large sample of older patients using the
VA healthcare system, those with new-onset epilepsy
had more admissions compared to similar patients with-
out epilepsy. Our study also highlights the association of
multiple comorbidities and race/ethnicity with hospitali-
zation among older veterans, and, strikingly, of alcohol
dependence (see Figure 1). Alcohol dependence in the
elderly is under-diagnosed yet a major factor in hospita-
lizations in this age group [18].
Echoing prior population-based studies, TIGER
patients with new-onset epilepsy showed more than
doubled rates of cerebrovascular disease, dementia, and
psychiatric disorders - conditions associated with or
sharing etiology with epilepsy. Future studies could
examine which medical conditions present at the onset
of epilepsy may contribute more to the increase in
admissions, and how these affect a patient’sc o u r s eo f
treatment. In this elderly sample, epilepsy imparted an
increased risk of both medical and psychiatric admission
by a factor of 3 and 6, respectively.
The incidence of epilepsy noted among these VA
patients aged 66 years or older (156 cases/100,000
patients) is well above the range in population-based
studies reviewed by Banerjee and colleagues, 16-51 per
100,000 [3]. The high incidence in this VA sample may
be attributable to their elderly age, patient status, and to
the generally high comorbidity seen in the VA patient
population [19]. The VA preferentially provides care to
veterans who are sicker, more disabled, impoverished, or
combat-exposed.
The findings regarding race/ethnicity are of note.
Unexpectedly, minority race/ethnicity patients with
new-onset epilepsy were at higher risk for hospitaliza-
tion for medical reasons compared to patients not iden-
tified as white. At the same time, Hispanic ethnicity was
associated with less risk of psychiatric admission in the
total-sample analysis (but not in the new-onset epilepsy
sub-analysis). In other words, non-white patients had
relatively higher risk of medical admission, and the
effect was stronger for non-white patients with new-
onset epilepsy. The Selim physical comorbidity scores
for Hispanic patients (2.8 +/- 1.9) were marginally lower
than those of white patients (2.9 +/- 2.0); African-Amer-
ican patients had slightly higher scores (3.3 +/- 2.1) and
were also more likely to have new-onset epilepsy.
Whether non-white patients have less physiological
reserve to cope with new-onset epilepsy, or differences
in the specific comorbid conditions account for admis-
sion differences, is unclear.
TIGER patients hospitalized with a primary diagnosis
of psychiatric disorder, epilepsy, or non-epilepsy medical
conditions had notable differences in neurological and
psychiatric comorbidity. A new diagnosis of epilepsy in
a geriatric patient should not be viewed as an event
easily dismissed with the prescription of an anti-epileptic
drug. Rather the clinician should view this development
as one attended by high risk of hospitalization and asso-
ciated with a complex care plan. Furthermore, this may
be a signal to consider caretaker availability, health edu-
cation needs, and potentially end-of-life planning. In
addition, limitations in patient-provider communication
often arise for mental health patients, such that recogni-
tion of medical needs may be impeded in psychiatric
patients. Clinicians who are not mental health specialists
may want to consult with a geriatric psychiatrist to opti-
mize a coordinated treatment plan, while mental health
professionals will want to establish cooperative relation-
ships with the medical specialists.
Comorbidity in epilepsy patients has been studied in
o n l yaf e wl a r g es t u d i e s ,n o t a b l yt h eC a n a d i a na n dU n i -
ted Kingdom studies already cited, where high rates of
digestive system disorders, stroke, respiratory disorders,
dementia, migraine and other pain conditions as well as
doubled co-occurring psychiatric disorders were noted
[2,4]. VA patients are generally sicker than US residents
[19]. The “protective” effect of peripheral vascular dis-
ease, which was inversely associated with psychiatric
hospitalization among new-onset epilepsy, and the few
other inversely related associations noted in the geriatric
population (tables 2 and 3), merit further research but
may be artifacts of the analysis, which estimated effects
for a very large number of conditions simultaneously.
Limitations of this study include reliance on adminis-
trative data, gathered for purposes other than the
Figure 1 Selected Factors Contrasting Odds Ratios Associated
with Medical Admission and Those Associated with Psychiatric
Admission among Geriatric Patients with New-Onset Epilepsy
(OR = 1 is n.s.)
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be of interest, such as severity of illness scales and sub-
jective experience reports. An additional limitation is
uncertainty regarding the onset of epilepsy, as a person
may have a seizure disorder for some time before it is
recognized by diagnosis and treatment. Finally, the ger-
iatric VA patient population is primarily male, reflecting
military recruitment patterns, and VA patients are less
healthy and wealthy than US residents in general [19],
thus these results may not generalize to healthier
patients nor to women.
Conclusion
Our findings highlight the role psychiatric and physi-
cal conditions play in both medical and psychiatric
hospitalizations. Regardless of the type of hospitaliza-
tion, substance abuse, dementia and cerebrovascular
disease were strong risk factors for admission. Recog-
nition of medical and mental health comorbidities is
essential for appropriate treatment on both an inpati-
ent and outpatient basis, and research is needed to
determine whether race/ethnicity may play a role in
the likelihood of admission type, considering that
there may be underlying medical or equity issues to
disentangle.
In assessing the inpatient care required by elderly VA
patients, our examination of medical and psychiatric
admissions found both considerable overlap between
groups characterized by psychiatric and neurological
conditions, and a large impact on inpatient utilization of
epilepsy. From the patient point of view, having epilepsy
appeared to increase the risk of medical admission as
well as of psychiatric admission. From an analytic per-
spective, omitting epilepsy and other neurological condi-
tions may lead to overestimation of the risk of
admission attributable solely to psychiatric or common
medical conditions. Finally, evaluated from a health sys-
tems, policy and resource allocation perspective, the
emerging picture of the psychiatric epilepsy patient,
characterized by a great need for healthcare resources,
may merit development of practice guidelines to
improve coordinated outpatient care and reduce
demand on the healthcare system. As the Baby Boomer
cohort ages into late life over the next two decades, this
patient population and its healthcare needs are likely to
expand greatly.
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